ES2116989T3 - Parche con elevado contenido de sustancias suavizantes. - Google Patents

Parche con elevado contenido de sustancias suavizantes.

Info

Publication number
ES2116989T3
ES2116989T3 ES91110409T ES91110409T ES2116989T3 ES 2116989 T3 ES2116989 T3 ES 2116989T3 ES 91110409 T ES91110409 T ES 91110409T ES 91110409 T ES91110409 T ES 91110409T ES 2116989 T3 ES2116989 T3 ES 2116989T3
Authority
ES
Spain
Prior art keywords
parts
weight
patch
high content
softening substances
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91110409T
Other languages
English (en)
Inventor
Walter Dr Dipl-Chem Muller
Geb Heidemann Raphael Minderop
Andreas Dr Teubner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Application granted granted Critical
Publication of ES2116989T3 publication Critical patent/ES2116989T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/58—Adhesives
    • A61L15/585—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Materials Engineering (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Botany (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Road Signs Or Road Markings (AREA)
  • Laminated Bodies (AREA)
  • Tea And Coffee (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)

Abstract

LA INVENCION TRATA DE UN DISPOSITIVO PARA SUMINISTRAR TOPICA Y SISTEMATICAMENTE EN Y A TRAVES DE LA PIEL, QUE CONSTE DE UNA TAPA QUE SE PEGUE SOLA Y UNA CAPA PROTECTORA QUE SE APARTE OTRA VEZ LA CUAL ESTA CARACTERIZADA POR QUE LA CAPA DE AUTOPEGADO A) SE COMPONGA DE 100 PARTES DE PESO DE UN ADHESIVO DE POLIACRILATO, B) DE 5 A 150 PREFERENTEMENTE DE 10 A 100 Y ESPECIALMENTE MEJOR DE 15 A 50 PARTES DE PESO DE UN MODELADOR DE UNA PELICULA TOLERANTE CON POLIACRILATO, C) DE 0 A 250 PARTES DE PESO DE ACTIVADOR Y/O MATERIAS AUXILIARES QUE NO SE ABLANDEN Y D) DE 10 A 250 PARTES DE PESO DE ACTIVADOR Y/O MATERIALES AUXILIARES QUE SE PLASTIFIQUEN.
ES91110409T 1990-06-25 1991-06-24 Parche con elevado contenido de sustancias suavizantes. Expired - Lifetime ES2116989T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4020144A DE4020144A1 (de) 1990-06-25 1990-06-25 Pflaster mit hohem gehalt an weichmachenden inhaltsstoffen

Publications (1)

Publication Number Publication Date
ES2116989T3 true ES2116989T3 (es) 1998-08-01

Family

ID=6409004

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91110409T Expired - Lifetime ES2116989T3 (es) 1990-06-25 1991-06-24 Parche con elevado contenido de sustancias suavizantes.

Country Status (11)

Country Link
US (1) US5306503A (es)
EP (1) EP0464573B1 (es)
JP (1) JP2700362B2 (es)
AT (1) ATE164769T1 (es)
CA (1) CA2045290C (es)
DE (2) DE4020144A1 (es)
DK (1) DK0464573T3 (es)
ES (1) ES2116989T3 (es)
FI (1) FI111338B (es)
IE (1) IE912181A1 (es)
NO (1) NO301049B1 (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW221970B (es) * 1991-06-26 1994-04-01 Tbs Lab Inc
DE4229230C2 (de) * 1992-09-02 1997-01-16 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit Pentetrazol als Wirkstoff
DE4336557C2 (de) * 1993-05-06 1997-07-17 Lohmann Therapie Syst Lts Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
DE4333595A1 (de) * 1993-10-01 1995-04-06 Labtec Gmbh Transdermales therapeutisches System zur Applikation von Arzneimitteln auf die Haut
DE4403487C2 (de) * 1994-02-04 2003-10-16 Lohmann Therapie Syst Lts Arznei-Pflaster mit UV-vernetzbaren Acrylat-Copolymeren
DE4406332C1 (de) * 1994-02-28 1995-06-22 Sanol Arznei Schwarz Gmbh Pharmazeutische Verwendung von Nitroglycerin zur Verhinderung unerwünschter Wehentätigkeit bei Säugern in einer transdermalen Applikationsform
FR2719770A1 (fr) * 1994-05-11 1995-11-17 Lhd Lab Hygiene Dietetique Système matriciel pour administration transdermique d'ibuprofène et procédé de préparation.
ATE194281T1 (de) * 1994-09-14 2000-07-15 Minnesota Mining & Mfg Matrix für transdermale wirkstofffreisetzung
AU6032696A (en) * 1995-06-07 1996-12-30 Cygnus Therapeutic Systems Pressure sensitive acrylate adhesive composition cross-linke d with aluminum acetylacetonate and containing a drug having a reactive aromatic hydroxyl group
DE19526864A1 (de) * 1995-07-22 1997-01-23 Labtec Gmbh Hormonpflaster
US8084051B1 (en) * 1995-11-13 2011-12-27 Bio Med Sciences, Inc. Therapeutic medical garments with silicone sheeting component for scar treatment, process of manufacture and use
DE19650471A1 (de) * 1996-12-05 1998-06-10 Beiersdorf Ag Wirkstoffhaltige Pflaster
DE19653606A1 (de) * 1996-12-20 1998-06-25 Roehm Gmbh Haft- und Bindemittel aus (Meth)acrylatpolymer, organischer Säure und Weichmacher
DE19700913C2 (de) 1997-01-14 2001-01-04 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Abgabe von Hormonen
DE19706824C1 (de) * 1997-02-21 1998-03-26 Lohmann Therapie Syst Lts Transdermales oder topisches Plastersystem mit Polyacrylatmatrix mit verbesserten physikalischen Eigenschaften
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
DE19830649C2 (de) 1998-07-09 2003-04-10 Lohmann Therapie Syst Lts Topisches Pflaster mit nichtsteroidalen Antirheumatika mit Säuregruppe
DE19830651A1 (de) * 1998-07-09 2000-01-13 Lohmann Therapie Syst Lts Steroidhaltiges Pflaster, Verfahren zu seiner Herstellung und Verwendung
DE19834496B4 (de) * 1998-07-31 2004-02-26 Beiersdorf Ag Verbesserte Freisetzung von Ibuprofen aus Heißschmelzklebemassen in wirkstoffhaltigen Pflastern durch Zusatz von pharmazeutischen Hilfsstoffen und Verwendung von Hilfsstoffen zur Verbesserung der Freisetzung von Ibuprofen
US6475514B1 (en) 1998-12-03 2002-11-05 Andrew Blitzer Athletic patch
US20030170195A1 (en) * 2000-01-10 2003-09-11 Noven Pharmaceuticals, Inc. Compositions and methods for drug delivery
EP1061900B2 (en) * 1999-01-14 2008-07-09 Noven Pharmaceuticals, Inc. Dermal compositions
RO121628B1 (ro) * 1999-02-05 2008-01-30 Cipla Limited Compoziţie medicinală, topică, pulverizabilă,dozator care o conţine, procedeu de realizare a dozatorului şi utilizarea compoziţiei menţionate
DE19911262C2 (de) * 1999-03-13 2003-04-10 Scs Skin Care Systems Gmbh Vorrichtung zur Abgabe kosmetischer Wirkstoffe
DE19923427A1 (de) * 1999-05-21 2000-11-23 Lohmann Therapie Syst Lts Vorrichtung und Verfahren zur Steigerung der transdermalen Permeation von Arzneistoffen
DE19940238A1 (de) 1999-08-25 2001-03-01 Lohmann Therapie Syst Lts Wirkstoffhaltiges therapeutisches System zur Applikation auf der Haut mit mindestens zwei polymerhaltigen Schichten
US6168028B1 (en) 1999-11-19 2001-01-02 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Packaged skin product
DE10032537A1 (de) * 2000-07-05 2002-01-31 Labtec Gmbh Dermales System, enthaltend 2-(3-Benzophenyl)Propionsäure
DE10049225A1 (de) * 2000-09-28 2002-04-11 Labtec Gmbh Dermales System, enthaltend Diclofenac
TWI287455B (en) * 2000-12-05 2007-10-01 Noven Pharma Crystallization inhibition of drugs in transdermal drug delivery systems and methods of use
DE10060550C1 (de) * 2000-12-06 2002-04-18 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit dem Wirkstoff Oxybutynin und Verfahren zur Herstellung Oxybutynin enthaltender Wirkstoffschichten
DE10103860B4 (de) 2001-01-30 2004-12-23 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System für die Verabreichung carboxylgruppenhaltiger, nichtsteroidaler Antiphlogistika, sowie Verfahren zu seiner Herstellung
DE10121471A1 (de) * 2001-05-02 2002-11-07 Beiersdorf Ag Oberflächendotierte wirkstoffhaltige Pflaster
US20050100588A1 (en) * 2001-06-13 2005-05-12 Beiersdorf Ag Self-adhesive matrix plaster containing an active ingredient and based on polyurethane gels
US20050085652A1 (en) * 2003-04-08 2005-04-21 Algorx Pharmaceuticals, Inc. Preparation and purification of synthetic capsaicin
AU2004235794B8 (en) * 2003-04-30 2009-07-23 Purdue Pharma L.P. Tamper-resistant transdermal dosage form comprising an active agent component and an adverse agent component at the distal site of the active agent layer
US8790689B2 (en) 2003-04-30 2014-07-29 Purdue Pharma L.P. Tamper resistant transdermal dosage form
WO2006058140A2 (en) * 2004-11-24 2006-06-01 Algorx Pharmaceuticals, Inc. Capsaicinoid gel formulation and uses thereof
ITMI20050084A1 (it) * 2005-01-21 2006-07-22 Biofarmitalia Spa Tessuto composito flessibile traspirante formato da strati di materiale tessile separati e tra di loro accoppiati da uno strato di polimero adesivo
HRP20171260T1 (hr) * 2007-01-11 2017-10-20 Drossapharm Ag Medicinski aktivni flaster
US12186426B2 (en) 2009-10-30 2025-01-07 Ix Biopharma Ltd. Solid dosage form
ES2712989T3 (es) 2009-10-30 2019-05-17 Ix Biopharma Ltd Forma de dosificación sólida de disolución rápida
DE102012000369A1 (de) 2012-01-11 2013-07-11 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Transdermales therapeutisches System mit Cholinesterase-Hemmer
US20140083878A1 (en) * 2012-09-21 2014-03-27 Mylan Inc. Transdermal drug delivery device

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5843368B2 (ja) * 1980-10-30 1983-09-27 日東電工株式会社 消炎鎮痛貼付剤
JPS5910513A (ja) * 1982-07-12 1984-01-20 Nitto Electric Ind Co Ltd 医薬製剤
JPS60123417A (ja) * 1983-12-07 1985-07-02 Nitto Electric Ind Co Ltd 薬物投与部材
HU197847B (en) * 1984-03-01 1989-06-28 Sandoz Ag Process for producing therapeutical preparations suitable for transdermatic treating
JPS60224638A (ja) * 1984-04-23 1985-11-09 Kao Corp 経皮吸収促進剤およびこれを含有する外用剤
JPS60252412A (ja) * 1984-05-29 1985-12-13 Nichiban Co Ltd 貼布治療製剤
DE3634016A1 (de) * 1986-04-17 1987-10-29 Lohmann Gmbh & Co Kg Flaechenfoermiges therapeutisches system, verfahren zu seiner herstellung und seine verwendung
EP0249343B1 (en) * 1986-06-13 1992-01-08 Alza Corporation Moisture activation of transdermal drug delivery system
DE3629304A1 (de) * 1986-08-28 1988-03-24 Lohmann Gmbh & Co Kg Transdermales therapeutisches system, seine verwendung und verfahren zu seiner herstellung
JPS63201119A (ja) * 1987-02-17 1988-08-19 Kao Corp 貼付剤組成物
DE3714140A1 (de) * 1987-04-28 1988-11-10 Lohmann Therapie Syst Lts Wirkstoffhaltiges pflaster zur kontrollierten verabreichung von wirkstoffen an die haut, seine verwendung sowie verfahren zur gesteuerten verabreichung von wirkstoffen an die haut
US4956181A (en) * 1987-05-08 1990-09-11 Eastman Kodak Nitrate therapy for angina pectoris
DE3743946A1 (de) * 1987-09-01 1989-03-09 Lohmann Gmbh & Co Kg Vorrichtung zur abgabe von nitroglycerin an die haut, verfahren zu ihrer herstellung sowie ihre verwendung
US4994267A (en) * 1988-03-04 1991-02-19 Noven Pharmaceuticals, Inc. Transdermal acrylic multipolymer drug delivery system
DE3807283A1 (de) * 1988-03-05 1989-09-14 Basf Ag Verfahren zur herstellung eines pflasters zur transdermalen anwendung pharmazeutischer wirkstoffe
DE3843238C1 (es) * 1988-12-22 1990-02-22 Lohmann Therapie Syst Lts
DE3843239C1 (es) * 1988-12-22 1990-02-22 Lohmann Therapie Syst Lts
DE3901551A1 (de) * 1989-01-20 1990-07-26 Lohmann Therapie Syst Lts Superfizielles therapeutisches system mit einem gehalt an einem antineoplastischen wirkstoff, insbesondere 5-fluoruracil

Also Published As

Publication number Publication date
DE4020144A1 (de) 1992-01-09
JPH04230212A (ja) 1992-08-19
NO912466L (no) 1991-12-27
EP0464573B1 (de) 1998-04-08
NO301049B1 (no) 1997-09-08
FI913072L (fi) 1991-12-26
CA2045290A1 (en) 1991-12-26
DK0464573T3 (da) 1999-01-11
US5306503A (en) 1994-04-26
FI913072A0 (fi) 1991-06-24
DE4020144C2 (es) 1993-07-29
NO912466D0 (no) 1991-06-24
CA2045290C (en) 2002-02-05
EP0464573A1 (de) 1992-01-08
IE912181A1 (en) 1992-01-01
FI111338B (fi) 2003-07-15
ATE164769T1 (de) 1998-04-15
JP2700362B2 (ja) 1998-01-21
DE59108962D1 (de) 1998-05-14

Similar Documents

Publication Publication Date Title
ES2116989T3 (es) Parche con elevado contenido de sustancias suavizantes.
ES2160854T3 (es) Composiciones cosmeticas para el cabello o la piel a base de copoliesteres sulfonados con restos poliorganosiloxanos.
DE68924111D1 (de) UV-härtbare Siloxanzusammensetzung enthaltend einen Haftver- mittler.
ES2111155T3 (es) Pelicula multicapa con un aspecto opaco.
ES2145763T3 (es) Articulos absorbentes higienicos.
BR8103497A (pt) Agantes absorvedores de luz ultra-violeta e composiceos e artigos que contem os mesmos
ES2151543T3 (es) Pelicula abollonada de varias capas.
ES2025642T3 (es) Composiciones de caucho de silicona.
AR247994A1 (es) Un producto abrasivo revestido y procedimiento para su fabricacion.
MX9301071A (es) Articulo abrasivo.
AR230650A1 (es) Composicion para el pulido de superficies y el articulo de pulimiento que la contiene
ES2147957T3 (es) Cinta autoadhesiva a base de poliuretano.
ATE72726T1 (de) Verwendung eins pflanzensubstrates.
ES2179213T3 (es) Composicion para la administracion transdermica.
ES2118249T3 (es) Parche que contiene dexpanthenol para la aplicacion percutanea de hormonas esteroideas.
ES2154064T3 (es) Recipiente provisto de un pincel para un adhesivo de cianoacrilato.
MX9207094A (es) Composicion adhesiva sensible a la presion.
BR8103498A (pt) Gentes absorvedores de luz ultra-violeta e composicoes e artigos que contem os mesmos
ES2045719T3 (es) Cinta autoadhesiva, sin soporte, adherente por ambas caras.
ES2039592T3 (es) Cabeza magnetica.
MX9205743A (es) Material monolaminar o multilaminar, reciclable, con caracteristicas de barrera contra la humedad y los gases, y un procedimiento para su fabricacion.
OA06658A (fr) Unité de conditionnement sous la forme de récipients ou de chapelet de récipients en matière synthétique souple.
NO855322L (no) Laminatmateriale som inneholder fluorert polyethylen og artikler laget av materialet.
ES2015850A4 (es) Cola para materiales plasticos y procedimiento para la formacion de esta cola.
BR0016202A (pt) Tambor de embalagem com um adesivo fundido e enchimento do adesivo

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 464573

Country of ref document: ES